116
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Correlation between enzyme multiplied immunoassay technique and high-performance liquid chromatography in the quantification of voriconazole in a paediatric population

, , , , &
Pages 121-126 | Received 16 Aug 2020, Accepted 20 Dec 2020, Published online: 10 Jan 2021

References

  • Moriyama B, Kadri S, Henning SA, et al. Therapeutic drug monitoring and genotypic screening in the clinical use of voriconazole. Curr Fungal Infect Rep. 2015;9(2):74–87.
  • Miyakis S, van Hal SJ, Ray J, et al. Voriconazole concentrations and outcome of invasive fungal infections. Clin Microbiol Infect. 2010;16(7):927–933.
  • Howard A, Hoffman J, Sheth A. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis. Ann Pharmacother. 2008;42(12):1859–1864.
  • Chen K, Zhang X, Ke X, et al. Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, Chinese Pharmacological Society. Ther Drug Monit. 2018;40(6):663–674.
  • Smith A, Dowis J, French D. Quantification of serum voriconazole, isavuconazole, and posaconazole by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Curr Protoc Toxicol. 2018;76(1):e47.
  • Gomez-Lopez A, Cendejas-Bueno E, Cuesta I, et al. Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients. Med Mycol. 2012;50(4):439–445.
  • Yuan G, Liu H, Shaikh AS, et al. Comparison of new liquid chromatography-mass spectrometry method and enzyme-multiplied immunoassay technique for routine therapeutic drug monitoring of vancomycin in Chinese patients. Clin Lab. 2018;64(3):277–285.
  • Irtan S, Azougagh S, Monchaud C, et al. Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients. Pediatr Nephrol. 2008;23(10):1859–1865.
  • Zhihui K. Correlation study and clinical application of HPLC and EMIT method in the determination of voriconazole in patients plasma [master’s thesis]. Jinan (SD): Shandong University 2018. Chinese.
  • Cattoir L, Fauvarque G, Degandt S, et al. Therapeutic drug monitoring of voriconazole: validation of a novel ARK immunoassay and comparison with ultra-high performance liquid chromatography. Clin Chem Lab Med. 2015;53:e135–e139.
  • Langman LJ, Boakye-Agyeman F. Measurement of voriconazole in serum and plasma. Clin Biochem. 2007;40(18):1378–1385.
  • Xuejuan L, Sixi L, Zebin C, et al. Determination of voriconazole in human plasma by HPLC. J China Pharm. 2017;28:4499–4502.
  • Michael C, Teichert J, Preiss R. Determination of voriconazole in human plasma and saliva using high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;865(1–2):74–80.
  • Okur NÜ, ÇaĞlar EŞ, Yozgatli V. Development and validation of an Hplc method for voriconazole active substance in bulk and its pharmaceutical formulation. Marmara Pharm J. 2016;20(2):79–85.
  • Ashbee HR, Barnes RA, Johnson EM, et al. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother. 2014;69(5):1162–1176.
  • Yi WM, Schoeppler KE, Jaeger J, et al. Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study. Ann Clin Microbiol Antimicrob. 2017;16(1):60.
  • Vena A, Munoz P, Mateos M, et al. Therapeutic drug monitoring of antifungal drugs: another tool to improve patient outcome? Infect Dis Ther. 2020;9(1):137–149.
  • Chawla PK, Dherai AJ, Ashavaid TF. Plasma voriconazole estimation by HPLC. Indian J Clin Biochem. 2016;31(2):209–214.
  • Chen B, Gu Z, Chen H, et al. Establishment of high-performance liquid chromatography and enzyme multiplied immunoassay technology methods for determination of free mycophenolic acid and its application in Chinese liver transplant recipients. Ther Drug Monit. 2010;32:653–660.
  • Veringa A, Ter Avest M, Span LF, et al. Voriconazole metabolism is influenced by severe inflammation: a prospective study. J Antimicrob Chemother. 2017;72(1):261–267.
  • Jeu L, Piacenti FJ, Lyakhovetskiy AG, et al. Voriconazole. Clin Ther. 2003;25(5):1321–1381.
  • Xingxian L, Lin H, Taifeng L, et al. High performance liquid chromatography coupling with photo-diode array detector method for monitoring voriconazole and its main metabolite N-oxidized voriconazole and its application to medicationguidance for childhood leukemia. Chin Pharm J. 2019;54:1169–1175.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.